Clinical Microbiology Market, Opportunities, Past Data, Share, Size, SWOT Analysis, Trend Comment 2021 – 2028

Report Summary:

At a CAGR of 6.9% over the forecast period, it is expected that the size of the worldwide clinical microbiology market will increase from USD 12.3 billion in 2020 to USD 20.1 billion by 2028. For both established and up-and-coming product manufacturers, the global microbiological testing/clinical microbiology market provides tremendous growth potential. One of the main factors propelling the development of the microbiological testing/clinical microbiology market is the increase in financing and public-private investments, rising incidence of infectious diseases and growing occurrence of epidemics (like COVID-19), and technological improvements.

​​​​​​​COVID-19 Impact on the global clinical microbiology market:

The clinical microbiology market has been considerably impacted by the COVID-19 pandemic. In the manufacturing and supply chain, the market must address issues including timely product delivery to end users and unequal demand for the goods and services offered in the industry. The availability of clinical microbiology products to end users has also decreased as a result of a lack of trained lab personnel to perform/study diagnostic tests, limited operations in the majority of industries, insufficient funding for research and academic institutes, the temporary closure of major academic institutes, disrupted supply chains, and difficulties in providing necessary/post-sales services because of lockdowns. One of the main final users of clinical microbiology products is research institutions. This end-user segment has been severely impacted over the past few months due to the pandemic’s temporary shutdown of numerous research institutes around the world.

Request Access Full Report is Available:@

Dynamics of the Clinical Microbiology Market

Driver: Enhanced medical diagnostic technology

A number of newly developed molecular diagnostic methods are being employed more frequently for both the early identification and efficient treatment of pathogen-borne disorders. In comparison to conventional laboratory procedures, advanced molecular diagnostic techniques offer a number of technological advantages, including a quicker turnaround time, a high sample throughput, multiplexing of reactions, specificity, higher accuracy, and increased device sensitivity.

Restraint: Limited reimbursement policies for procedures involving microbiological testing

Many nations with large target patient populations, like China, India, and other developing nations in the Middle East and Africa, do not sufficiently compensate the costs of clinical microbiological testing methods. This is a significant limiting factor for patients’ and healthcare workers’ desire for clinical microbiology products.

Opportunity: enhancing healthcare systems in emerging nations

Manufacturers and distributors of clinical microbiology products should see significant growth prospects over the course of the projection period as a result of emerging markets. The rising incidence of infectious diseases including HIV, TB, influenza, and malaria as well as increased R&D efforts to provide cutting-edge genomic tools for effective disease diagnosis in underdeveloped countries might be credited for this.

Operational difficulties with the utilisation of diagnostic testing pose a problem.

Different types of patient samples, including semen, saliva, tissue, blood, and urine, are used in diagnostic microbiological testing. These diagnostic procedures only sometimes use automated tools to identify common diseases including Plasmodium, Staphylococcus, and E. coli.

Request a Sample Copy of the Research Report:@

Key Market Players:

Hologic Inc.; Roche Diagnostics; bioMerieux S.A.; Cepheid Inc.; Alere Inc., Becton Dickinson & Company; Danaher Corporation; and Bruker Corporation.

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Leave a Reply

Your email address will not be published.